Showing results (251-260 of 433) with videos related to

Sort By:
Pageof 44
Cancer Research|November 4, 2005
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug developmentCarleen Cullinane, Donna S Dorow, Maya Kansara, et al.
EJNMMI Radiopharmacy and Chemistry|November 26, 2024
Preclinical evaluation and automated synthesis of [89Zr]ZrDFOSquaramide-girentuximab for diagnostic imaging of carbonic anhydrase IX positive tumoursAsif Noor, Emily R McGowan, Jessica K Van Zuylekom, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 17, 2009
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumourEddie W F Lau, Katharine J Drummond, Robert E Ware, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2017
Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and PheochromocytomaGrace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, et al.
Molecular Cancer Therapeutics|June 3, 2011
In vivo activity of combined PI3K/mTOR and MEK inhibition in a Kras(G12D);Pten deletion mouse model of ovarian cancerKathryn M Kinross, Daniel V Brown, Margarete Kleinschmidt, et al.
The American Journal of Medicine|March 15, 2002
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphomaAndrew Wirth, John F Seymour, Rodney J Hicks, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2013
The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival dataMichael P Mac Manus, Sarah Everitt, Mike Bayne, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2012
Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patientsStephen D Guy, Adrian R Tramontana, Leon J Worth, et al.
Journal of Pediatric Hematology/Oncology|August 22, 2015
Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic NeuroblastomaGrace Kong, Michael S Hofman, William K Murray, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 24, 2023
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphomaVijay Mistry, Justin R Scott, Tzu-Yang Wang, et al.
Pageof 44